Lupin shares

Buy these stocks in November and sell in December

Seasonality suggests November softness and December strength, yet select Pharma counters consistently outperform. Three stocks offering the favourable risk-reward from…

November 11, 2025 05:30 IST

Motilal Oswal buy ratings, Petronet LNG share price target, VA Tech Wabag stock outlook, Prince Pipes and Fittings share target

3 ‘Buy’ recommendations by Nomura, with up to 21% upside potential

Nomura suggests 3 ‘Buy’ stocks with up to 21% potential gains — discover which picks could boost your returns! Read…

September 30, 2025 13:33 IST

Trump’s tariff threats are spooking pharma. Are MNC stocks the answer?

Investors are increasingly turning to ‘safer’ MNC pharma stocks with a domestic focus at a time when the Trump administration…

August 19, 2025 15:49 IST

Lupin signs $50 million biosimilar licensing deal with Zentiva

Lupin inks $50 million licensing deal with Zentiva for global biosimilar rollout

Lupin has signed a $50 million licensing deal with Zentiva for the global commercialization of its biosimilar Certolizumab Pegol, targeting…

July 9, 2025 11:00 IST

Three reasons why pharma stocks are falling today?

Pharma stocks are under significant selling pressure. Here is a detailed analysis on the top worries for the sector.

Updated: March 25, 2025 14:45 IST

Lupin share price today, Lupin share news

Lupin shares gain nearly 2% on strong Q2; Get your prescription for the stock

Lupin shares have shown strong growth, with a 3% return over the past three months and 30.65% over the last…

Updated: November 8, 2024 09:18 IST

Lupin stock rating ‘Accumulate’: 13% upside seen on gSpiriva launch, US market gains; check target price

Elara Capital has set a target price of Rs 992 on Lupin stock, which is an upside of 13%, with…

Updated: June 22, 2023 17:07 IST

Market awaits Lupin’s new product launch

Company anticipates Ebitda margin boost from gSpiriva in August.

May 16, 2023 01:35 IST

Rakesh Jhunjhunwala, Lupin, Fortis Healthcare, The Mandhana Retail Ventures, MCX, TARC

Rakesh Jhunjhunwala exits MCX, cuts stakes in 2 more firms after Lupin, Fortis Healthcare

Rakesh Jhunjhunwala has exited MCX, after trimming his stakes in at least four firms — Lupin, Fortis Healthcare, The Mandhana…

October 18, 2021 15:27 IST

Rakesh Jhunjhunwala trims stake in Fortis Healthcare even as stock rallies over 72% so far this year

Rakesh Jhunjhunwala has cut a stake in a healthcare firm Fortis Healthcare to 4.23 per cent

October 18, 2021 12:03 IST

Rakesh Jhunjhunwala, Lupin, pharma stocks

Rakesh Jhunjhunwala cuts stake in Lupin; stock remains under pressure, loses over 4% so far this year

Rakesh Jhunjhunwala has trimmed stake in pharma major Lupin to below one per cent.

October 14, 2021 12:29 IST

Ami Organics IPO, Ami Organicsgmp, Ami Organics grey market premium

Ami Organics IPO: Stock lists tomorrow, grey market premium strong; analysts see up to 35% listing gains

Ami Organics is scheduled to make its stock market debut on Tuesday, 14 September, after receiving over 64 times subscription…

September 13, 2021 12:26 IST

Rakesh Jhunjhunwala’s favorite stock Lupin tanks 17% in 7 days; should you buy, sell or hold?

Lupin share price fell nearly 2 per cent to Rs 958.70 apiece in intraday deals, following the April-June quarter earnings…

August 16, 2021 13:43 IST

Nifty, Bank Nifty outlook: Nifty to trade in 15,600-15,900 range, Bank Nifty may top 37,000; Infosys in focus

The chart pattern suggests that if Nifty crosses and sustains above 15950 level it would witness buying which would lead…

July 19, 2021 08:46 IST

Buy HDFC, Axis Bank, Lupin, M&M stocks to pocket gains; Nifty support at 15,700-15,750

On Wednesday 15900/15930 (53000/53100) would be major hurdles and support would be at 15730/52500 and 15700/52400 levels.

July 14, 2021 08:53 IST

Rakesh Jhunjhunwala-owned drug stock hits new 52-week high; charts show it may rally up to 20% more

Rakesh Jhunjhunwala-owned Lupin share price surged as high as 4.7 per cent to Rs 1,266.35 apiece in intraday deals on…

June 2, 2021 14:17 IST

Nifty may trade in 14,400-15,000 range this week, Bank Nifty below 20, 50, 100 day SMAs; Wipro, Cipla in focus

The chart pattern suggests that if Bank Nifty crosses and sustains above 33000 level it would witness buying which would…

May 17, 2021 08:34 IST

L&T, Cipla, Lupin, Dr Reddy's, Vedanta, stocks in focus

L&T, Cipla, Lupin, Dr Reddy’s, Vedanta, GAIL, Tata Power, Reliance Infrastructure stocks in focus

Nifty futures were trading 191.50 points or 1.32 per cent higher at 14,699 on Singaporean Exchange, indicating a strong opening…

May 14, 2021 08:17 IST

Related News

e-Passport launched in India: Who can apply, how to apply, application fee, benefits, key security upgrades and more

Dhurandhar Box Office collection Day 6: Ranveer Singh-Akshaye Khanna spy-thriller aims for Rs 250 crore week

Watchlist 2026: 3 super investor stocks trading at a 40%+ discount,

Damani, Jhunjhunwala & Nemish Shah: 3 ‘deep value’ picks down 40-80%

India's maritime MRO revolution: Aatmanirbhar Bharat's next frontier for shipping giants. (Image Source: Mazagondock)

Stop chasing shipbuilding. The real story is ship repair: 3 stocks to watch

Big income tax benefits under new labour laws: How revised wage definition works in your favour

Met Gala 2026: Beyoncé to return after 10 years; co-chairs to theme, all you need to know

Life1 hr ago

The Met Gala 2026, fashion’s biggest night, has announced its co-chairs and host committee, including Beyonce and Anna Wintour. The theme is ‘Costume Art’, exploring the body-clothing relationship. Tickets are priced at $50,000 and the event serves as a fundraiser for the Met Museum. Amazon’s Jeff Bezos and his wife are among the attendees.

View all shorts